EydisBio Email Formats

Biotechnology Research • Durham, North Carolina, United States • 1-10 Employees

EydisBio Email Formats

EydisBio uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@eydisbio.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@eydisbio.com	100%

Key Contact at EydisBio

Philip Hughes

Co-Founder

Company overview

Headquarters	201 West Main Street, Durham, North Carolina 27701-3228, US
Website	eydisbio.com
NAICS	541714
Employees	1-10
Socials

About EydisBio

EydisBio, Inc. is an early-stage biopharmaceutical company focused on developing potent and selective small molecule therapeutics targeting autoimmune and inflammatory disease with high unmet medical needs. EydisBio's TAK1 inhibitor program is primarily focused on targeting the over 40% of rheumatoid arthritis patients who either do not respond or lose response over time to approved anti-TNF biologics. Our highly potent and exquisitely selective, orally bioavailable TAK1 inhibitors are also being explored in additional autoimmune indications including the rare disease systemic sclerosis, viral-induced acute respiratory distress syndrome, and as an alternative to opioids in patients with chronic pain. We also have an oncology discovery program with promising early efficacy in treating patients with FLT3 mutation-positive AML and glioblastoma.